骨髓来源的RIPK3介导急性肾损伤中的肾脏炎症
研究利用骨髓嵌合小鼠探讨RIPK3在叶酸诱导的急性肾损伤(FA-AKI)及无肾细胞死亡的TWEAK模型中对肾脏炎症的作用。结果显示Ripk3缺陷减轻FA-AKI的NF-κB活化与炎症但不防止肾衰竭,骨髓来源表达RIPK3的细胞为FA-AKI早期炎症所必需,且RIPK3不依赖肾小管细胞死亡介导肾脏炎症。
要点
- Ripk3缺陷减轻FA-AKI的NF-κB活化与肾脏炎症,但不防止肾衰竭。
- 骨髓来源表达RIPK3的细胞为FA-AKI早期炎症所必需。
- RIPK3不依赖肾小管细胞死亡介导肾脏炎症。
核心结论
- RIPK3不依赖肾小管细胞死亡介导肾脏炎症。
- 特异性靶向骨髓来源的RIPK3可能限制肾脏炎症,且无全身靶向RIPK3的潜在不良反应。
研究设计与样本
- 使用野生型与Ripk3敲除小鼠骨髓构建的嵌合小鼠,探讨RIPK3在叶酸诱导的急性肾损伤(FA-AKI)及无AKI和肾细胞死亡的全身给予细胞因子TWEAK模型中对肾脏炎症的作用。
主要发现
- 小鼠AKI中肾小管和间质细胞RIPK3表达增加。
- Ripk3缺陷降低FA-AKI的NF-κB活化和肾脏炎症,但不防止肾衰竭。
- 嵌合小鼠中,表达RIPK3的骨髓来源细胞为FA-AKI早期炎症所必需。
- NLRP3炎症小体未参与RIPK3的促炎效应。
- 全身给予TWEAK在野生型而非Ripk3缺陷小鼠中诱导肾脏炎症。
临床怎么用
- 作者认为,特异性靶向骨髓来源的RIPK3可能限制肾脏炎症,且无全身靶向RIPK3的潜在不良反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Receptor-interacting protein kinase 3 (RIPK3), a component of necroptosis pathways, may have an independent role in inflammation. It has been unclear which RIPK3-expressing cells are responsible for the anti-inflammatory effect of overall Ripk3 deficiency and whether Ripk3 deficiency protects against kidney inflammation occurring in the absence of tubular cell death. METHODS: We used chimeric mice with bone marrow from wild-type and Ripk3-knockout mice to explore RIPK3's contribution to kidney inflammation in the presence of folic acid-induced acute kidney injury AKI (FA-AKI) or absence of AKI and kidney cell death (as seen in systemic administration of the cytokine TNF-like weak inducer of apoptosis [TWEAK]). RESULTS: Tubular and interstitial cell RIPK3 expressions were increased in murine AKI. Ripk3 deficiency decreased NF-κB activation and kidney inflammation in FA-AKI but did not prevent kidney failure. In the chimeric mice, RIPK3-expressing bone marrow-derived cells were required for early inflammation in FA-AKI. The NLRP3 inflammasome was not involved in RIPK3's proinflammatory effect. Systemic TWEAK administration induced kidney inflammation in wild-type but not Ripk3-deficient mice. In cell cultures, TWEAK increased RIPK3 expression in bone marrow-derived macrophages and tubular cells. RIPK3 mediated TWEAK-induced NF-κB activation and inflammatory responses in bone marrow-derived macrophages and dendritic cells and in Jurkat T cells; however, in tubular cells, RIPK3 mediated only TWEAK-induced Il-6 expression. Furthermore, conditioned media from TWEAK-exposed wild-type macrophages, but not from Ripk3-deficient macrophages, promoted proinflammatory responses in cultured tubular cells. CONCLUSIONS: RIPK3 mediates kidney inflammation independently from tubular cell death. Specific targeting of bone marrow-derived RIPK3 may limit kidney inflammation without the potential adverse effects of systemic RIPK3 targeting.
引用
- Martin-Sanchez D, Guerrero-Mauvecin J, Fontecha-Barriuso M, et al. Bone Marrow-Derived RIPK3 Mediates Kidney Inflammation in Acute Kidney Injury. J Am Soc Nephrol. 2022. PMID: 35046131. doi:10.1681/ASN.2021030383
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。